Effects of single nucleotide changes on the binding and activity of RNA aptamers to human papillomavirus 16 E7

Clare Nicol1, David H J Bunka, G Eric Blair

  • 1Institute of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.

Insights

Researchers developed RNA aptamers targeting the human papillomavirus 16 E7 oncoprotein. One aptamer inhibited E7

Area of Science:

  • Molecular Biology
  • Virology
  • Biotechnology

Background:

  • Human papillomavirus 16 (HPV16) oncoprotein E7 is crucial for cell transformation.
  • Targeting viral oncoproteins is a strategy for antiviral therapies.

Purpose of the Study:

  • To develop RNA aptamers against the HPV16 E7 oncoprotein.
  • To investigate the specificity and functional activity of these aptamers.

Main Methods:

  • Systematic Evolution of Ligands by Exponential Enrichment (SELEX) was used for aptamer development.
  • Functional assays were performed to assess aptamer inhibition of E7-pRb interaction.

Main Results:

  • Several RNA aptamers targeting HPV16 E7 were identified.
  • One aptamer demonstrated significant inhibition of the E7-pRb binding interaction.
  • Aptamers with >92% sequence similarity in random regions showed varied functional activity, highlighting specificity.

Conclusions:

  • RNA aptamers can be specifically developed to target viral oncoproteins like HPV16 E7.
  • Subtle sequence variations in aptamers can lead to significant differences in functional activity.
  • Aptamers show potential as specific inhibitors of viral oncoprotein interactions.

Related Concept Videos

Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...